Cordis Corporation: all 78 studies
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery DiseaseNot yet recruitingNCT07338890
- Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery StenosisRecruitingNCT07122518
- Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual CompressionCompletedNCT05554471Not applicableResults posted
- Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial AccessCompletedNCT05399680Not applicableResults posted
- Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure DeviceCompletedNCT03923387Not applicableResults posted
- European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic AneurysmsCompletedNCT02477111Results posted
- A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)CompletedNCT01664078Not applicableResults posted
- A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)CompletedNCT01106391Not applicableResults posted
- CYPRESS - CYPHER for Evaluating Sustained SafetyStatus unknownNCT00954707Phase 4Results posted
- S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery DiseaseCompletedNCT00739102Not applicableResults posted
- Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent SystemsStatus unknownNCT00715884Not applicableResults posted
- Safety and Effectiveness Study of the Ensure Medical Vascular Closure DeviceCompletedNCT00345631Phase 3Results posted
- Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232739Phase 3Results posted
- NEXUS Study for the Treatment of de Novo Native Coronary Artery LesionsCompletedNCT00231283Phase 3Results posted
- Mobilization and Outcomes After Venous ClosureCompletedNCT07246902
- PMCF Study of Precise Pro Rx for Carotid Artery DiseaseCompletedNCT07204678
- PMCF Study for Cardiology Access ProceduresCompletedNCT05543096
- PMCF Study for Peripheral Arteries Below the Knee (BTK)CompletedNCT05444660
- PMCF Study for Peripheral Arteries Above the Knee (ATK)CompletedNCT05312580
- China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)WithdrawnNCT03965364
- Compassionate Use of the Incraft® AAA Stent Graft SystemNo longer availableNCT01776450
- Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent SystemCompletedNCT01355406Not applicable
- An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)TerminatedNCT01202058Phase 3
- Cynergy: the CYPHER-NEVO RegistryTerminatedNCT01106378
- The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)CompletedNCT00974181Phase 3
- French Post-Marketing Surveillance SurveyTerminatedNCT00855478Phase 4
- The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.CompletedNCT00749424Phase 4
- A Study of the Presillion Stent in de Novo Coronary LesionsCompletedNCT00722579Phase 3
- Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery LesionsTerminatedNCT00714883Phase 2
- Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial DiseaseCompletedNCT00640770Phase 4
- Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery LesionsTerminatedNCT00606333Not applicable
- ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EUCompletedNCT00574691Phase 1
- Plug Arterial Closure System (PACS, 7F)CompletedNCT00533156Phase 2
- Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis TrialCompletedNCT00497172Phase 4
- A Study of Diabetic Patients With De Novo Native Coronary Artery LesionsCompletedNCT00495898Phase 4
- An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).CompletedNCT00489320
- Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery LesionsTerminatedNCT00489164Phase 1/2
- A Multi-center Post-Market Surveillance RegistryCompletedNCT00438919Phase 4
- The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)CompletedNCT00403338
- SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for EndarterectomyCompletedNCT00403078
- The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.CompletedNCT00381420Phase 3
- The Intra-Drug Eluting Stent (DES) Restenosis StudyCompletedNCT00323895Phase 4
- A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)CompletedNCT00322569Phase 3
- The Study to Compare SMART Nitinol Stent and Balloon AngioplastyCompletedNCT00309595Phase 4
- The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions.TerminatedNCT00289055Phase 4
- The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.CompletedNCT00264043Phase 2/3
- Distal Protection Combined With PTCA in AMI PatientsCompletedNCT00264030Phase 2
- CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)CompletedNCT00245401Phase 4
- The Arterial Revascularization Therapies Study Part II.CompletedNCT00235170Phase 3
- A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.CompletedNCT00235157Phase 2
- The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.CompletedNCT00235144Phase 3
- The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ StentCompletedNCT00235131Phase 4
- Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)CompletedNCT00235118Phase 1/2
- The REALITY Study - Head-to-Head Comparison Between Cypher and TaxusCompletedNCT00235092Phase 4
- The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.CompletedNCT00235066Phase 4
- A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.CompletedNCT00234455Phase 2
- FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity StentCompletedNCT00233818Phase 1/2
- The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.CompletedNCT00233805Phase 2
- FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY StentCompletedNCT00233792Phase 1/2
- Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)CompletedNCT00233779Phase 2
- Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)CompletedNCT00233766Phase 1/2
- Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)CompletedNCT00233740Phase 4
- Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery LesionsCompletedNCT00233714Phase 1/2
- Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)CompletedNCT00233688Phase 3
- A Study of the SMART Stent in the Treatment SFA Disease.CompletedNCT00232869Phase 2
- A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.CompletedNCT00232856Phase 4
- The Study to Treat Superficial Femoral Artery Occlusions.CompletedNCT00232843Phase 4
- The Study to Assess AMI Treated With Balloon Angioplasty.CompletedNCT00232830Phase 3
- The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher StentCompletedNCT00232804Phase 4
- The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.CompletedNCT00232791Phase 2/3
- A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)CompletedNCT00232778Phase 1/2
- Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)CompletedNCT00232765Phase 3
- Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232752Phase 3
- Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)CompletedNCT00231270Phase 3
- Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)CompletedNCT00231257Phase 3
- Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)CompletedNCT00231244Phase 3
- Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)CompletedNCT00231231Phase 3
- Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)CompletedNCT00165035Phase 3